Bioactivity | IRAK4-IN-4 is an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor extracted from patent CN107163044A, Compound15, has an IC50 of 2.8 nM. IRAK4-IN-4 also inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM[1]. | ||||||||||||
Target | IC50: 2.8 nM (IRAK4), 2.1 nM (cGAS) | ||||||||||||
Name | IRAK4-IN-4 | ||||||||||||
CAS | 1850276-58-2 | ||||||||||||
Formula | C22H16N2O2 | ||||||||||||
Molar Mass | 340.37 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. One class has the naphthalene second dione compounds and its derivative of protease modification activities. CN107163044A. |